1. Home
  2. HOLX vs FFIV Comparison

HOLX vs FFIV Comparison

Compare HOLX & FFIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOLX
  • FFIV
  • Stock Information
  • Founded
  • HOLX 1985
  • FFIV 1996
  • Country
  • HOLX United States
  • FFIV United States
  • Employees
  • HOLX N/A
  • FFIV N/A
  • Industry
  • HOLX Medical Electronics
  • FFIV Computer Communications Equipment
  • Sector
  • HOLX Health Care
  • FFIV Telecommunications
  • Exchange
  • HOLX Nasdaq
  • FFIV Nasdaq
  • Market Cap
  • HOLX 18.3B
  • FFIV 15.2B
  • IPO Year
  • HOLX 1990
  • FFIV 1999
  • Fundamental
  • Price
  • HOLX $71.47
  • FFIV $252.00
  • Analyst Decision
  • HOLX Buy
  • FFIV Hold
  • Analyst Count
  • HOLX 13
  • FFIV 9
  • Target Price
  • HOLX $89.50
  • FFIV $237.11
  • AVG Volume (30 Days)
  • HOLX 2.1M
  • FFIV 504.7K
  • Earning Date
  • HOLX 01-30-2025
  • FFIV 01-27-2025
  • Dividend Yield
  • HOLX N/A
  • FFIV N/A
  • EPS Growth
  • HOLX 81.42
  • FFIV 45.80
  • EPS
  • HOLX 3.32
  • FFIV 9.55
  • Revenue
  • HOLX $4,030,300,000.00
  • FFIV $2,816,120,000.00
  • Revenue This Year
  • HOLX $1.73
  • FFIV $6.78
  • Revenue Next Year
  • HOLX $4.07
  • FFIV $3.79
  • P/E Ratio
  • HOLX $21.68
  • FFIV $26.39
  • Revenue Growth
  • HOLX N/A
  • FFIV 0.10
  • 52 Week Low
  • HOLX $70.24
  • FFIV $159.01
  • 52 Week High
  • HOLX $84.67
  • FFIV $264.50
  • Technical
  • Relative Strength Index (RSI)
  • HOLX 25.18
  • FFIV 52.23
  • Support Level
  • HOLX $74.71
  • FFIV $254.27
  • Resistance Level
  • HOLX $74.02
  • FFIV $264.50
  • Average True Range (ATR)
  • HOLX 1.81
  • FFIV 4.32
  • MACD
  • HOLX -0.52
  • FFIV -0.78
  • Stochastic Oscillator
  • HOLX 0.45
  • FFIV 16.50

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

About FFIV F5 Inc.

F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.

Share on Social Networks: